1. Introduction
===============

The incidence of fetal cardiovascular malformation has increased in recent years, and the prognosis is extremely poor. Early diagnosis is crucial, the methods for diagnosing fetal malformation mainly include computed tomography (CT), magnetic resonance imaging (MRI), and ultrasonography.[@R1] Among them, ultrasound has become the preferred method for diagnosing fetal congenital cardiovascular malformation because of its simple operation, low cost, no ionizing radiation, and real-time dynamics.^\[[@R2],[@R3]\]^ Ultrasound screening of fetal cardiovascular malformations in early pregnancy gradually plays a very important role in the regulation of pregnancy.[@R4] Combined with considerations such as maternal age, serum biochemistry, ultrasound abnormalities, and other ultrasound markers, ultrasound screening can identify most chromosomal abnormalities or abnormalities in the body.^\[[@R5],[@R6]\]^ In the early pregnancy examination, if the transparent layer of the fetal neck is found to be increased and has normal karyotype, the risk of congenital heart disease is significantly increased.^\[[@R7],[@R8],[@R9]\]^ A foreign study also showed that fetuses with tricuspid regurgitation in early pregnancy screening also have a significantly increased risk of chromosomal and congenital heart disease.^\[[@R10],[@R11]\]^ This study analyzed the results of ultrasound diagnosis in the first trimester and the second trimester of fetuses diagnosed with congenital heart malformations, and compared the types of congenital heart malformations, accompanying diseases and fetal outcomes, in order to clarify the advantages of early screening.

2. Materials and methods
========================

2.1. General Information
------------------------

From January 2013 to June 2018, pregnant women were under ultrasound screening in Qilu Hospital of Shandong University, and 230 fetuses were diagnosed with congenital heart malformations. According to the time of initial ultrasound screening and disease diagnosis, fetuses were divided into 2 groups: Group A (early pregnancy group) including 70 cases of fetal diagnosed with congenital heart disease in early pregnancy (11^+0^ weeks--13^+6^ weeks). Group B (second trimester of pregnancy group) including 160 cases diagnosed with congenital heart disease in the second trimester (14^+0^ weeks--28^+0^ weeks). In addition, 347 fetuses that underwent a mid-pregnancy check and diagnosed with congenital heart disease during the period 1998 to 2005 were collected as group C. The study was approved by the Ethics Committee of Qilu Hospital of Shandong University. Informed consent was signed before the study began.

2.2. Research methods
---------------------

The GEE8 color Doppler ultrasound system (probe frequency 3--5 MHz) was used to change the probe angle based on the 4-chamber view (4CV) to obtain the 3-vessel plane (3VV), the 3-vessel-tracheal plane (3VVT), the aortic root-axial section (AR-SAV), and left and right ventricular outflow tract (VOTV). The heart chamber, ventricular septum, atrial septum, cardiac outflow tract, heart valve morphology, and cardiac blood flow characteristics were observed, and various cardiovascular malformations were identified.

2.3. Test indicators
--------------------

The success rate of different ultrasound section showing fetal cardiovascular malformation was observed. The types of congenital heart malformations, concomitant diseases, and fetal outcomes were compared. 66 cases of pregnancies diagnosed with congenital heart disease in the first trimester completed genetic consultation and karyotype analysis before delivery, while 164 cases diagnosed in the second trimester completed genetic testing after delivery. Fetal cells derived from chorionic villus or amniocentesis was used for analyzing prenatal cytology and molecular genetics.

2.4. Statistical methods
------------------------

The data were analyzed by Statistical Package for the Social Sciences (SPSS) version 20.0 software (SPSS, Inc., Chicago, IL). The *t* test was used for the analysis of the measurement data between the groups. The analysis of the measurement data was performed by χ^2^ test. *P* \<.05 showed that the difference was statistically significant.

3. Results
==========

3.1. The display rate of different ultrasound section to the fetal cardiovascular malformation
----------------------------------------------------------------------------------------------

As demonstrated in Figure [1](#F1){ref-type="fig"}, the 4-chamber view had the lowest display rate of fetal cardiovascular malformation (56.5%), while the 4-chamber + 3-vessel-tracheal plane showed the highest display rate of fetal cardiovascular malformation (95.6%). The difference between the various sections was statistically significant (*P* \<.05).

![Display rate of different ultrasound section in fetal cardiovascular malformations.](medi-98-e16822-g001){#F1}

3.2. Prenatal ultrasound diagnosis of fetal heart malformation
--------------------------------------------------------------

It was suggested that compared with the 2 groups, the percentage of cases with atrioventricular septal defect (AVSD) (*P* = .045), left ventricular dysplasia (HLHS) (*P* \<.001), pulmonary atresia (PA) (*P* = .032), and tricuspid atresia (TA) (*P* = .021) diagnosed in group A was significantly higher than that in group B, the difference was statistically significant (*P* \<.05). The percentage of transposition of the great arteries (TGA) (*P* = .024) and pulmonary stenosis (PS) (*P* \<.001) screened in the second trimester was significantly different from that in the early pregnancy group. In addition, more fetuses were diagnosed with a right ventricular dual outflow tract, aortic coarctation, and vascular annulus in the second trimester (Table [1](#T1){ref-type="table"}).
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Comparison of the types and quantities of 3 groups of prenatal ultrasound diagnosis of congenital heart disease.
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In addition, the mid-pregnancy detection rate of AVSD, HLHS, PA, and ventricular double inlet (DIV) before 2005 was significantly upregulated after 2013. On the other hand, the detection rate of TGA, tetralogy of Fallot (TOF), aortic atresia (AS) (*P* = .040), aortic coarctation (CoA), PS, and vascular ring (VR) was significantly higher in Group B than that in Group C (Table [1](#T1){ref-type="table"}).

3.3. Comparison of associated diseases and fetal outcomes
---------------------------------------------------------

Compared with group A, the percentage of cases with the chromosomal abnormalities and/or non-cardiac malformations, simple chromosomal abnormalities, structural abnormalities associated with non-cardiac, congenital heart disease with single ventricular circulation, intrauterine death, and termination of pregnancy was significantly decreased in group B (*P* \<.05) (Table [2](#T2){ref-type="table"}). Furthermore, compared with group B, the proportion of non-cardiac structural malformation diseases, congenital heart disease with single ventricular circulation, intrauterine death and termination of pregnancy in group C was significantly increased (*P* \<.05). However, there was no difference in accompanying disease, chromosomal abnormality between group B and group C (*P* \>.05).
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Comparison of prenatal ultrasound diagnosis of concomitant diseases, cardiac cycle types and fetal outcomes in 3 groups.
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3.4. Comparison of the types and numbers of chromosomal abnormalities in 3 groups
---------------------------------------------------------------------------------

Results in Table [3](#T3){ref-type="table"} indicated that, compared with group A, less fetuses with chromosomal abnormality trisomy 21, 18, 13 syndromes and Turner syndrome were screened in group B, and the difference was significant (*P* \<.001). Moreover, the percentage of fetuses with 22q11 deletion showed no difference between group A and group B (*P* \>.05). Compared with group B, less fetuses with 22q11 deletion were screened in group C (*P* = .014), while the percentage of fetuses with chromosomal abnormality, trisomy 21, 18, 13 syndromes, and Turner syndrome showed no difference between 2 groups (*P* \>.05).

###### 

Comparison of the types and quantities of chromosomal abnormalities in 3 groups.
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4. Discussion
=============

In the screening for fetal malformations including congenital heart malformations, early pregnancy screening has an important impact on mid-pregnancy screening and an effect on the outcome of congenital heart disease after birth that cannot be ignored.[@R12] Combining the special medical history of pregnant women, ultrasound examinations, and serum biochemical indicators can prompt screening for some major chromosomal abnormalities at 11 to 13 weeks of pregnancy, including some structural abnormalities, cardiac abnormalities, and some complications.

The 4-chamber view is the basic level of the heart examination and can show the shape and structure of the left and right atrium and ventricle. ^\[[@R13],[@R14]\]^ This study showed that early pregnancy ultrasound screening plays a crucial role in the diagnosis of cardiovascular malformation. It was also proved that the display rate of fetal cardiovascular malformation detected by the 4-chamber heart + 3-vessel-tracheal plane is higher than that of the typical 4-chamber view.

Previous studies have reported that the spectrum and incidence of disease found in prenatal and postnatal screening are different.^\[[@R15],[@R16]\]^ This study also confirmed that the types and incidence of cardiac malformations screened in early pregnancy and mid-pregnancy are also inconsistent. The reason is because in the early pregnancy, the incidence of severe congenital heart disease is higher, and often accompanied by other system abnormalities, eventually leading to an increased probability of intrauterine death. The difference in the overall detection rate of different types of cardiac malformations also affects the type of disease detected during the first trimester and the second trimester.[@R17] The most common types of congenital heart disease detected during the first trimester are some morphological abnormalities that can be clearly seen during prenatal screening. Similar to the study of Matalon et al[@R18], the rate of AVSD and HLHS screened in early pregnancy reaches 44.3% in this study. In an early pregnancy study, Chameides et al found that 69% of the fetuses have AVSD or HLHS.[@R19] In the second trimester study, in addition to AVSD and HLHS, the diagnosis of other cardiac malformations requires observational assessment of large vessels (TGA, PS, right aortic arch, CoA, and AS) because blood vessels are constantly developing during pregnancy. Before 2005, early pregnancy screening was not yet popular. After 2013, early routine screening of pregnant women with high-risk pregnancies had a great impact on mid-pregnancy screening. More AVSD, HLHS, and PA were detected in 1998 to 2005 compared to the mid-pregnancy screenings of 2013 to 2018. Consistently, early pregnancy screening during the period 2013 to 2018 found more AVSD, HLHS, and PA than mid-pregnancy screening. Further studies found that in the mid-pregnancy screening during different periods, the number of non-cardiac malformations, congenital heart disease with single ventricular circulation, intrauterine death, and premature termination of pregnancy was significantly decreased in the later stages compared to the early stages due to the high screening rate of severe congenital heart disease and the high early termination of pregnancy rate in early pregnancy. In previous reports, the detection rate of fetal chromosomal abnormalities is 16% to 50%.^\[[@R20],[@R21],[@R22]\]^ In the 2013 to 2018 screening, the study found that the risk of cardiac malformation is significantly promoted in the early stages of pregnancy in comparison with other periods, and often accompanied by chromosomal abnormalities. In the early pregnancy, 47.1% of congenital heart fetuses are associated with chromosomal abnormalities, while in foreign reports, the proportion is as high as 72.09%.[@R12] In the mid-pregnancy screening of the first 2 periods, the detection rates are 17.5% and 17.3%, respectively. Above findings indicate that the chromosomal abnormalities diagnosed in early pregnancy are significantly higher than those in the second trimester.

5. Conclusions and limitations
==============================

In summary, the spectrum and incidence of congenital heart disease detected in early pregnancy and mid-pregnancy screening are different. Early pregnancy screening has an important impact on the outcome of a fetus with congenital heart disease, because at this stage, severe heart malformations, chromosomal abnormalities, and more complications are more likely to be discovered, resulting in more termination of pregnancy in early pregnancy. This study is beneficial to improve health problems of children in society. However, there are a few limitations: the small sample size, no information on the health status of the parents, and no analysis in correlations of congenital heart disease with the job of the parents.
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